Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Blood pressure effects of CPAP in nonresistant and resistant hypertension associated with OSA: A systematic review of randomized clinical trials.

Clinical and experimental hypertension (New York, N.Y. : 1993)·2016
Same author

Lowering blood pressure to prevent stroke recurrence: a systematic review of long-term randomized trials.

Journal of the American Society of Hypertension : JASH·2014
Same author

Early treatment of hypertension in acute ischemic and intracerebral hemorrhagic stroke: progress achieved, challenges, and perspectives.

Journal of the American Society of Hypertension : JASH·2013
Same author

Nocturia in arterial hypertension: a prevalent, underreported, and sometimes underestimated association.

Journal of the American Society of Hypertension : JASH·2013
Same author

Association between chronic blood pressure changes and development of Alzheimer's disease.

Journal of Alzheimer's disease : JAD·2012
Same author

Effects of blood pressure changes on Alzheimer's disease.

Neuroepidemiology·2010

Related Experiment Video

Updated: Jul 4, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Statins as antihypertensives.

Carlos A Feldstein1

  • 1Hypertension Program, Hospital de Clínicas José de San Martín, University of Buenos Aires, Buenos Aires, Argentina. carlfel@yahoo.com

Recent Patents on Cardiovascular Drug Discovery
|June 10, 2008
PubMed
Summary

Statins offer cardiovascular benefits in hypertension through pleiotropic vascular effects, independent of cholesterol reduction. They provide modest blood pressure lowering, particularly in uncontrolled cases, aiding disease prevention.

Area of Science:

  • Cardiovascular Pharmacology
  • Endocrinology
  • Vascular Biology

Background:

  • Hypertension management involves addressing endothelial dysfunction and vascular inflammation.
  • Statins are primarily known for cholesterol reduction but exhibit broader vascular effects.
  • Pleiotropic actions of statins may impact blood pressure regulation and cardiovascular risk.

Purpose of the Study:

  • To review the beneficial effects of statins in hypertension.
  • To explore the mechanisms underlying statins' impact on vascular function and blood pressure.
  • To identify patient subgroups who may benefit most from statin therapy in hypertension.

Main Methods:

  • Review of existing scientific literature on statins, hypertension, and vascular biology.

Related Experiment Videos

Last Updated: Jul 4, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

  • Analysis of studies investigating statins' effects on endothelial function, renin-angiotensin system, and arterial compliance.
  • Examination of evidence for pleiotropic effects occurring before lipid-lowering.

    • Main Results:

    • Statins improve endothelial function, increase nitric oxide (NO) synthesis, and inhibit vascular smooth muscle cell proliferation.
    • They possess anti-inflammatory and anti-oxidative properties, downregulating angiotensin II type 1 receptor expression.
    • Statins demonstrate a modest blood pressure-lowering effect, most significant in poorly controlled hypertension.
    • These vascular benefits manifest prior to significant changes in cholesterol levels.

    Conclusions:

    • Statins offer cardiovascular protection in hypertensive patients through pleiotropic vascular actions.
    • They are beneficial in specific hypertensive populations, including those with high cholesterol, poorly controlled BP, or elevated C-reactive protein.
    • Further research is warranted to define statins' role in preventing or delaying hypertension progression.